Shawn Marcell

DropWorks, Inc. is developing groundbreaking instrumentation and analytical techniques using novel continuous flow droplet nanoreactors. Our early focus is on digital PCR, where our simple workflow, high throughput, and low cost can provide absolute quantification and ultra-high sensitivity for less work and less money than qPCR. In the research space, we will enable the rapid development of both drugs and biomarkers. Our integrated microfluidic technology brings digital PCR to the field in a compact, portable form factor, enabling our users to bring a molecular biology laboratory anywhere. DropWorks is led by an executive team with extensive startup experience and high technical expertise. We are currently looking for talented research and support staff to join our team at the company's headquarters in Boulder, Colorado.

Sempresto is co-founded and led by a team of experienced life sciences, Pharma, and medical professionals with a shared experience with severe allergies. Our goal is to improve the utilization of life-saving epinephrine during anaphylactic emergencies by making the medication more convenient to carry and available anytime, anywhere. Leveraging the power of connected devices, we aim to support patients wherever they are.

Development stage biotech start-up

Torus Biosystems was spun out from the Wyss Institute for Biologically Inspired Engineering at Harvard University in 2020 to develop and commercialize the proprietary DNA/RNA detection technology developed by Wyss Core Faculty member, Peng Yin, PhD, Professor, Department of Systems Biology, Harvard Medical School, and Wyss Alumnus David Zhang, PhD, Associate Professor of Bioengineering, Rice University. Learn more about how Torus Bio can help improve patient outcomes, combat antibiotic resistance, and promote antimicrobial stewardship in a wide range of ambulatory settings including Hospital Outpatient and Emergency Departments and Long-Term Care facilities. Visit the website at www.torus.bio and connect with on social media @Twitter and @LinkedIn.

DropWorks, Inc. is developing groundbreaking instrumentation and analytical techniques using novel continuous flow droplet nanoreactors. Our early focus is on digital PCR, where our simple workflow, high throughput, and low cost can provide absolute quantification and ultra-high sensitivity for less work and less money than qPCR. In the research space, we will enable the rapid development of both drugs and biomarkers. Our integrated microfluidic technology brings digital PCR to the field in a compact, portable form factor, enabling our users to bring a molecular biology laboratory anywhere. DropWorks is led by an executive team with extensive startup experience and high technical expertise. We are currently looking for talented research and support staff to join our team at the company's headquarters in Boulder, Colorado.